Page last updated: 2024-09-03

sch 39370 and Cardiac Failure

sch 39370 has been researched along with Cardiac Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charles, CJ; Espiner, EA; Fitzpatrick, MA; Nicholls, MG; Rademaker, MT; Richards, AM; Sybertz, E1
Kokkonen, JO; Kovanen, PT; Kuoppala, A; Lindstedt, KA; Saarinen, J1
Johnston, CI; Murohara, Y1
Charles, CJ; Espiner, EA; Fitzpatrick, MA; Ikram, H; Rademaker, MT; Sybertz, E; Yandle, TG1
Fyhrquist, F; Helin, K; Saijonmaa, O; Sariola, H; Sybertz, EJ; Tikkanen, I; Tikkanen, T; Vemulapalli, S1
Fyhrquist, F; Helin, K; Näveri, H; Sariola, H; Sybertz, EJ; Tikkanen, I; Tikkanen, T; Vemulapalli, S1

Other Studies

6 other study(ies) available for sch 39370 and Cardiac Failure

ArticleYear
Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
    Journal of cardiovascular pharmacology, 1996, Volume: 27, Issue:3

    Topics: Animals; Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dipeptides; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hemodynamics; Neprilysin; Sheep

1996
Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
    Circulation, 1999, Apr-20, Volume: 99, Issue:15

    Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Bradykinin; Captopril; CD13 Antigens; Dipeptides; Female; Glycopeptides; Heart Failure; Humans; Kallidin; Leucine; Male; Membrane Proteins; Middle Aged; Myocardium; Neprilysin; Peptides; Peptidyl-Dipeptidase A; Protease Inhibitors; Substrate Specificity

1999
Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
    Clinical and experimental pharmacology & physiology, 1992, Volume: 19, Issue:5

    Topics: Animals; Atrial Natriuretic Factor; Cardiac Output; Cyclic GMP; Dipeptides; Female; Heart Failure; Hemodynamics; Kidney; Pharmaceutical Vehicles; Protease Inhibitors; Rats; Rats, Inbred Strains; Vascular Resistance; Ventricular Function, Left

1992
Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Journal of cardiovascular pharmacology, 1992, Volume: 19, Issue:4

    Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Blood Pressure; Cattle; Cyclic GMP; Dipeptides; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Injections, Intravenous; Natriuresis; Neprilysin

1992
Prolonged neutral endopeptidase inhibition in heart failure.
    European journal of pharmacology, 1991, May-30, Volume: 198, Issue:1

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Chromatography, High Pressure Liquid; Cyclic GMP; Dipeptides; Endopeptidases; Heart Failure; Hemodynamics; Kidney; Kidney Function Tests; Male; Metalloendopeptidases; Protease Inhibitors; Pulse; Rats; Rats, Inbred Strains; Renin; Water-Electrolyte Balance

1991
Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 254, Issue:2

    Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dipeptides; Heart Failure; Hematocrit; Injections, Subcutaneous; Male; Metalloendopeptidases; Organ Size; Potassium; Radioimmunoassay; Rats; Rats, Inbred Strains; Renin; Sodium

1990